Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Windecker

Showing results (941-950 of 1,158) with videos related to

Pageof 116
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 20, 2019
Impact of established cardiovascular disease on outcomes in the randomized global leaders trialScot Garg, Ply Chichareon, Norihiro Kogame, et al.
Atherosclerosis|February 2, 2020
Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS studyPly Chichareon, Rodrigo Modolo, Norihiro Kogame, et al.
JAMA|March 18, 2015
Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trialDean J Kereiakes, Robert W Yeh, Joseph M Massaro, et al.
JAMA Cardiology|November 7, 2019
Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical TrialPly Chichareon, Rodrigo Modolo, Laura Kerkmeijer, et al.
European Heart Journal. Digital Health|July 31, 2024
Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation studyKonstantinos C Siontis, Mikolaj A Wieczorek, Maren Maanja, et al.
The American Journal of Cardiology|June 13, 2024
One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney DiseaseNader Mankerious, Ralph Toelg, Birgit Vogel, et al.
Journal of the American College of Cardiology|August 28, 2023
Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering TherapyFlavio G Biccirè, Jonas Häner, Sylvain Losdat, et al.
JACC. Cardiovascular Interventions|February 19, 2025
1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCIVijay Kunadian, Mauro Gitto, Birgit Vogel, et al.
JACC. Cardiovascular Interventions|March 7, 2020
DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCIPly Chichareon, Rodrigo Modolo, Hideyuki Kawashima, et al.
European Heart Journal|December 8, 2022
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trialsFrancesco Costa, Claudio Montalto, Mattia Branca, et al.
Pageof 116

Showing results (941-950 of 1,158) with videos related to

Sort By:
Pageof 116
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 20, 2019
Impact of established cardiovascular disease on outcomes in the randomized global leaders trialScot Garg, Ply Chichareon, Norihiro Kogame, et al.
Atherosclerosis|February 2, 2020
Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS studyPly Chichareon, Rodrigo Modolo, Norihiro Kogame, et al.
JAMA|March 18, 2015
Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trialDean J Kereiakes, Robert W Yeh, Joseph M Massaro, et al.
JAMA Cardiology|November 7, 2019
Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical TrialPly Chichareon, Rodrigo Modolo, Laura Kerkmeijer, et al.
European Heart Journal. Digital Health|July 31, 2024
Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation studyKonstantinos C Siontis, Mikolaj A Wieczorek, Maren Maanja, et al.
The American Journal of Cardiology|June 13, 2024
One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney DiseaseNader Mankerious, Ralph Toelg, Birgit Vogel, et al.
Journal of the American College of Cardiology|August 28, 2023
Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering TherapyFlavio G Biccirè, Jonas Häner, Sylvain Losdat, et al.
JACC. Cardiovascular Interventions|February 19, 2025
1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCIVijay Kunadian, Mauro Gitto, Birgit Vogel, et al.
JACC. Cardiovascular Interventions|March 7, 2020
DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCIPly Chichareon, Rodrigo Modolo, Hideyuki Kawashima, et al.
European Heart Journal|December 8, 2022
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trialsFrancesco Costa, Claudio Montalto, Mattia Branca, et al.
Pageof 116